title: The use of activated factor VII for ventricular septal defect closure in a pediatric patient with hemophilia A and a high titer of inhibitor.
authors.affiliation: Department of Anesthesiology, University of Virginia, Charlottesville, VA 22908-0710, USA. dgd6n@virginia.edu
authors.forename: Duncan G
authors.initials: DG
authors.lastname: de Souza
authors.forename: Peter E
authors.initials: PE
authors.lastname: Waldron
authors.forename: Benjamin B
authors.initials: BB
authors.lastname: Peeler
authors.forename: Victor C
authors.initials: VC
authors.lastname: Baum
mesh_terms: D019774:Blood Coagulation Factor Inhibitors / Q000096:biosynthesis / Q000097:blood*; D015941:Complement Hemolytic Activity Assay; D015942:Factor VIIa / Q000627:therapeutic use*; D006345:Heart Septal Defects, Ventricular / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006467:Hemophilia A / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male
chemical_list: D019774:Blood Coagulation Factor Inhibitors; D015942:Factor VIIa